Cadrenal Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Cadrenal Therapeutics has a total shareholder equity of $3.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $4.7M and $1.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$4.36m |
| Equity | US$3.41m |
| Total liabilities | US$1.27m |
| Total assets | US$4.68m |
Financial Position Analysis
Short Term Liabilities: CVKD's short term assets ($4.7M) exceed its short term liabilities ($1.3M).
Long Term Liabilities: CVKD has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: CVKD is debt free.
Reducing Debt: CVKD had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CVKD has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: CVKD has less than a year of cash runway if free cash flow continues to reduce at historical rates of 63.2% each year